|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 31827 |
FusionGeneSummary for RPL19_ITLN1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: RPL19_ITLN1 | Fusion gene ID: 31827 | Hgene | Tgene | Gene symbol | RPL19 | ITLN1 | Gene ID | 6143 | 55600 |
| Gene name | ribosomal protein L19 | intelectin 1 | |
| Synonyms | L19 | HL-1|HL1|INTL|ITLN|LFR|hIntL|omentin | |
| Cytomap | 17q12 | 1q23.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | 60S ribosomal protein L19large ribosomal subunit protein eL19 | intelectin-1ITLN-1endothelial lectin HL-1galactofuranose-binding lectinintelectin 1 (galactofuranose binding)intestinal lactoferrin receptor | |
| Modification date | 20180523 | 20180527 | |
| UniProtAcc | P84098 | Q8WWA0 | |
| Ensembl transtripts involved in fusion gene | ENST00000225430, ENST00000579374, ENST00000579260, ENST00000582193, | ENST00000326245, ENST00000487531, | |
| Fusion gene scores | * DoF score | 4 X 4 X 4=64 | 4 X 2 X 3=24 |
| # samples | 4 | 4 | |
| ** MAII score | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/24*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: RPL19 [Title/Abstract] AND ITLN1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | RPL19 | GO:0002181 | cytoplasmic translation | 25957688 |
| Tgene | ITLN1 | GO:0001934 | positive regulation of protein phosphorylation | 16531507 |
| Tgene | ITLN1 | GO:0046326 | positive regulation of glucose import | 16531507 |
| Tgene | ITLN1 | GO:0070207 | protein homotrimerization | 26148048 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | MESO | TCGA-MQ-A6BR-01A | RPL19 | chr17 | 37357572 | + | ITLN1 | chr1 | 160846606 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000225430 | ENST00000326245 | RPL19 | chr17 | 37357572 | + | ITLN1 | chr1 | 160846606 | - |
| 5CDS-intron | ENST00000225430 | ENST00000487531 | RPL19 | chr17 | 37357572 | + | ITLN1 | chr1 | 160846606 | - |
| In-frame | ENST00000579374 | ENST00000326245 | RPL19 | chr17 | 37357572 | + | ITLN1 | chr1 | 160846606 | - |
| 5CDS-intron | ENST00000579374 | ENST00000487531 | RPL19 | chr17 | 37357572 | + | ITLN1 | chr1 | 160846606 | - |
| In-frame | ENST00000579260 | ENST00000326245 | RPL19 | chr17 | 37357572 | + | ITLN1 | chr1 | 160846606 | - |
| 5CDS-intron | ENST00000579260 | ENST00000487531 | RPL19 | chr17 | 37357572 | + | ITLN1 | chr1 | 160846606 | - |
| In-frame | ENST00000582193 | ENST00000326245 | RPL19 | chr17 | 37357572 | + | ITLN1 | chr1 | 160846606 | - |
| 5CDS-intron | ENST00000582193 | ENST00000487531 | RPL19 | chr17 | 37357572 | + | ITLN1 | chr1 | 160846606 | - |
Top |
FusionProtFeatures for RPL19_ITLN1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| RPL19 | ITLN1 |
| Lectin that specifically recognizes microbialcarbohydrate chains in a calcium-dependent manner(PubMed:11313366, PubMed:26148048). Binds to microbial glycansthat contain a terminal acyclic 1,2-diol moiety, including beta-linked D-galactofuranose (beta-Galf), D-phosphoglycerol-modifiedglycans, D-glycero-D-talo-oct-2-ulosonic acid (KO) and 3-deoxy-D-manno-oct-2-ulosonic acid (KDO) (PubMed:26148048). Binds toglycans from Gram-positive and Gram-negative bacteria, includingK.pneumoniae, S.pneumoniae, Y.pestis, P.mirabilis and P.vulgaris(PubMed:26148048). Does not bind human glycans (PubMed:26148048).Probably plays a role in the defense system against microorganisms(Probable). May function as adipokine that has no effect on basalglucose uptake but enhances insulin-stimulated glucose uptake inadipocytes (PubMed:16531507). Increases AKT phosphorylation in theabsence and presence of insulin (PubMed:16531507). May interactwith lactoferrin/LTF and increase its uptake, and may thereby playa role in iron absorption (PubMed:11747454, PubMed:23921499).{ECO:0000269|PubMed:11313366, ECO:0000269|PubMed:16531507,ECO:0000269|PubMed:23921499, ECO:0000269|PubMed:26148048,ECO:0000305, ECO:0000305|PubMed:11747454}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | >ITLN1 | chr17:37357572 | chr1:160846606 | ENST00000326245 | - | 6 | 8 | 262_263 | 263 | 314 | Region | Carbohydrate binding |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | ITLN1 | chr17:37357572 | chr1:160846606 | ENST00000326245 | - | 6 | 8 | 32_255 | 263 | 314 | Domain | Fibrinogen C-terminal |
Top |
FusionGeneSequence for RPL19_ITLN1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_RPL19_ENST00000225430_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_88aa >In-frame_RPL19_ENST00000579374_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_85aa >In-frame_RPL19_ENST00000579260_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_86aa >In-frame_RPL19_ENST00000582193_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_86aa |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_RPL19_ENST00000225430_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_265nt ATGAGTATGCTCAGGCTTCAGAAGAGGCTCGCCTCTAGTGTCCTCCGCTGTGGCAAGAAGAAGGTCTGGTTAGACCCCAATGAGACCAAT GAAATCGCCAATGCCAACTCCCCACTGCATTGGTGGAGGAGGATACTTTCCAGAGGCCAGTCCCCAGCAGTGTGGAGATTTTTCTGGTTT >In-frame_RPL19_ENST00000579374_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_256nt ATGAGGCTTCAGAAGAGGCTCGCCTCTAGTGTCCTCCGCTGTGGCAAGAAGAAGGTCTGGTTAGACCCCAATGAGACCAATGAAATCGCC AATGCCAACTCCCCACTGCATTGGTGGAGGAGGATACTTTCCAGAGGCCAGTCCCCAGCAGTGTGGAGATTTTTCTGGTTTTGATTGGAG >In-frame_RPL19_ENST00000579260_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_259nt ATGCTCAGGCTTCAGAAGAGGCTCGCCTCTAGTGTCCTCCGCTGTGGCAAGAAGAAGGTCTGGTTAGACCCCAATGAGACCAATGAAATC GCCAATGCCAACTCCCCACTGCATTGGTGGAGGAGGATACTTTCCAGAGGCCAGTCCCCAGCAGTGTGGAGATTTTTCTGGTTTTGATTG >In-frame_RPL19_ENST00000582193_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_259nt ATGCTCAGGCTTCAGAAGAGGCTCGCCTCTAGTGTCCTCCGCTGTGGCAAGAAGAAGGTCTGGTTAGACCCCAATGAGACCAATGAAATC GCCAATGCCAACTCCCCACTGCATTGGTGGAGGAGGATACTTTCCAGAGGCCAGTCCCCAGCAGTGTGGAGATTTTTCTGGTTTTGATTG |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_RPL19_ENST00000225430_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_452nt GCAGATAATGGGAGGAGCCGGGCCCGAGCGAGCTCTTTCCTTTCGCTGCTGCGGCCGCAGCCATGAGTATGCTCAGGCTTCAGAAGAGGC TCGCCTCTAGTGTCCTCCGCTGTGGCAAGAAGAAGGTCTGGTTAGACCCCAATGAGACCAATGAAATCGCCAATGCCAACTCCCCACTGC ATTGGTGGAGGAGGATACTTTCCAGAGGCCAGTCCCCAGCAGTGTGGAGATTTTTCTGGTTTTGATTGGAGTGGATATGGAACTCATGTT GGTTACAGCAGCAGCCGTGAGATAACTGAGGCAGCTGTGCTTCTATTCTATCGTTGAGAGTTTTGTGGGAGGGAACCCAGACCTCTCCTC CCAACCATGAGATCCCAAGGATGGAGAACAACTTACCCAGTAGCTAGAATGTTAATGGCAGAAGAGAAAACAATAAATCATATTGACTCA >In-frame_RPL19_ENST00000579374_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_410nt TCTTTCCTTTCGCTGCTGCGGCCGCAGCCATGAGGCTTCAGAAGAGGCTCGCCTCTAGTGTCCTCCGCTGTGGCAAGAAGAAGGTCTGGT TAGACCCCAATGAGACCAATGAAATCGCCAATGCCAACTCCCCACTGCATTGGTGGAGGAGGATACTTTCCAGAGGCCAGTCCCCAGCAG TGTGGAGATTTTTCTGGTTTTGATTGGAGTGGATATGGAACTCATGTTGGTTACAGCAGCAGCCGTGAGATAACTGAGGCAGCTGTGCTT CTATTCTATCGTTGAGAGTTTTGTGGGAGGGAACCCAGACCTCTCCTCCCAACCATGAGATCCCAAGGATGGAGAACAACTTACCCAGTA >In-frame_RPL19_ENST00000579260_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_787nt GCCATGAGGTGAGGGCGAGCTGGTCTCCATCAGGCGCTGACGCGTGTCGACAAGGGACTGTCGGTCTTGGGACCGCAGCTGGGGTTGGGG GAGATGAAATGGAGGCCGCCCTAAAGCGGCCGGTCCCGGGGTTTGGGGTAGGCCGGAGCACTTTCGTCCCGGGCCTCCGGAGTGAGGGGG GGCGGGGAGCGTCGCAGCAACTGAGACCAGGAAAAGTCTGCCCCGGCTGGTGCCGCACCGCACACGTGTCCGGTCGACCCACGCGAGCAG AGCAAACGGAGCGAACAAGACCAAGCCGTGGGCCCTTTCTTGCTTGGCACACCCGGAGCGGAGCCGATCTCTGCTTTCACGTGATGTAGG GCAAGCCTAGTGTAGGCCCCAGGCCTCCGACTGCCGAGAGAGTATGCTCAGGCTTCAGAAGAGGCTCGCCTCTAGTGTCCTCCGCTGTGG CAAGAAGAAGGTCTGGTTAGACCCCAATGAGACCAATGAAATCGCCAATGCCAACTCCCCACTGCATTGGTGGAGGAGGATACTTTCCAG AGGCCAGTCCCCAGCAGTGTGGAGATTTTTCTGGTTTTGATTGGAGTGGATATGGAACTCATGTTGGTTACAGCAGCAGCCGTGAGATAA CTGAGGCAGCTGTGCTTCTATTCTATCGTTGAGAGTTTTGTGGGAGGGAACCCAGACCTCTCCTCCCAACCATGAGATCCCAAGGATGGA >In-frame_RPL19_ENST00000582193_chr17_37357572_+_ITLN1_ENST00000326245_chr1_160846606_-_519nt ATGAGGTGAGGGCGAGCTGGTCTCCATCAGGCGCTGACGCGTGTCGACAAGGGACTGTCGGTCTTGGGACCGCAGCTGGGGTTGGGGGAG ATGAAATGGAGGCCGCCCTAAAGCGGCCGGTCCCGGGGTTTGGGTATGCTCAGGCTTCAGAAGAGGCTCGCCTCTAGTGTCCTCCGCTGT GGCAAGAAGAAGGTCTGGTTAGACCCCAATGAGACCAATGAAATCGCCAATGCCAACTCCCCACTGCATTGGTGGAGGAGGATACTTTCC AGAGGCCAGTCCCCAGCAGTGTGGAGATTTTTCTGGTTTTGATTGGAGTGGATATGGAACTCATGTTGGTTACAGCAGCAGCCGTGAGAT AACTGAGGCAGCTGTGCTTCTATTCTATCGTTGAGAGTTTTGTGGGAGGGAACCCAGACCTCTCCTCCCAACCATGAGATCCCAAGGATG |
Top |
FusionGenePPI for RPL19_ITLN1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| RPL19 | HDGF, ARRB2, SIRT7, TERF1, CUL3, CUL4A, CUL5, CUL2, CDK2, CUL1, COPS5, CAND1, NEDD8, RPL10A, RPL11, RPL12, RPL13, RPL14, RPL15, RPL18A, RPL18, RPL21, RPL22, RPL23, RPL24, RPL27A, RPL30, RPL31, RPL37A, RPL3, RPL4, RPL5, RPL6, RPL7A, RPL7, RPL9, RPS13, RPS14, RPS15A, RPS16, RPS17, RPS19, RPS23, RPS25, RPS26, RPS2, RPS3A, RPS3, RPS4X, RPS5, RPS6, RPS7, RPS8, RPSA, RPL8, RPL23A, RPS24, RPS11, RPS28, RPL10, RPS20, RPS12, RPLP0, RPL36, RPL27, RPS9, RPL17, RPL32, RPS27A, RPS21, NOP56, NCL, ILF3, RSL1D1, HNRNPU, GNL3, ILF2, SRP14, SLC25A5, EIF4A1, FBL, NOP58, TUFM, DDX21, NHP2L1, LUC7L2, NOLC1, HNRNPM, NIFK, NOP2, RPLP0P6, RPL10L, RPS27L, RRS1, SND1, PTGES3, GNB2L1, ECE1, NUP214, TUBB7P, DDX5, MRPL12, ESR1, MAGOH, EIF4A3, UBL4A, PAN2, IGSF8, ICAM1, COX11, YWHAQ, TARDBP, PARP1, KARS, NMT1, QARS, RPLP1, RPA3, RPA2, RPA1, STAU1, CEP250, TP53, CUL7, OBSL1, RNF2, RPS6KB2, RPL13A, RPL38, RPS29, RPL26, RPL28, RPL34, RPL35, RPL35A, RPL3L, RPLP2, RPS10, RPS15, RPS18, LOC101929876, SEC61A1, NTRK1, HIST1H3E, NPM1, E4F1, ZCRB1, SART3, H2AFX, CYLD, INO80B, TRIM25, YAP1, MTF1 | ITLN1 | CCND1, BCL2, ITLN2, NACC1, HSPA5, ENDOG, DNAJC12, RNASEH2A, RRAS, GSK3B, PICALM, SP3, TIPRL |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for RPL19_ITLN1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for RPL19_ITLN1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | ITLN1 | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | CTD_human |
| Tgene | ITLN1 | C0025500 | Mesothelioma | 1 | CTD_human |
| Tgene | ITLN1 | C0242698 | Ventricular Dysfunction, Left | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|